Abstract:BACKGROUND Intensive medical management has been recommended to ischemic stroke of intracranial atherosclerosis (ICAS), but 9.4-15% probability of recurrent stroke remains an inevitable reality. The characteristics of high-risk intracranial plaque that contribute to stroke recurrence after intensive therapy is unclear. METHODS All the patients for acute ischemic stroke due to ICAS underwent the 3D head&neck high-resolution vessel wall magnetic resonance imaging (hr-VW-MRI) at baseline and received intensive medical management within 90 days in this two-center and prospective study. The clinical risk factors and blood biomarkers were recorded. The morphological features, such as minimal lumen area (MLA), and histogram parameters including entropy were assessed based on MR images. The primary endpoint event after 6 months is recurrence of ischemic events (hyperintense signals on diffusion-weighted images or TIA in the ipsilateral vascular territory). Cox regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI) for recurrent events. RESULTS 222 patients (age, 59.5±12.1; males, 153) were included in the subsequent analysis. After an average of six months of follow-up (average days, 177.4±23.1), 38 patients have reached the primary endpoint. After adjusting the age, BMI and gender, the multivariate Cox regression demonstrated that three clinical factors including smoking (HR=4.321; 95%CI, 1.838-10.161; P =0.001), taking exercise (HR=0.409; 95%CI, 0.198-0.843; P =0.015) and blood pressure management (HR=0.180; 95%CI, 0.073-0.443; P =0.001), and two MR-related parameters (MLA [HR=0.771; 95%CI, 0.625-0.951; P =0.015] and entropy [HR=0.274; 95%CI, 0.130-0.576; P =0.001]) were significant predictors of recurrent ischemic stroke. The Kaplan– Meier curve depicted that the cumulative incidences of patients with all high-risk features were significantly higher than those without(P < 0.001). CONCLUSIONS The plaque characteristics based on 3D head&neck hr-VW-MRI may provide complementary values over traditional clinical features in predicting ischemic recurrence for ICAS and help risk stratification of patients at risk of recurrent stroke. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial This prospective study was not a clinical trial but an observational study for ICAS patients undergoing intensive medical management. And it was not an interventional study for medical treatment comparison. Additionally, the study was approved by the Institutional Review Board of Changhai Hospital of Shanghai (No.CHEC2018-092) and Zhongshan Hospital, Fudan University (No.B2022-112R), and written informed consent was obtained from all patients. ### Funding Statement This study was supported in part by the National Natural Science Foundation of China (No. 82202145) and the Pujiang Project of Shanghai Magnolia talent plan (23PJD012) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was approved by the Institutional Review Board of Changhai Hospital of Shanghai (No.CHEC2018-092) and Zhongshan Hospital, Fudan University (No.B2022-112R), and written informed consent was obtained from all patients. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Anonymized data not published within this article can be provided upon request by the corresponding author.

Correlation of the characteristics of symptomatic intracranial atherosclerotic plaques with stroke types and risk of stroke recurrence: a cohort study

Multiple predictors of in-stent restenosis after stent implantation in symptomatic intracranial atherosclerotic stenosis.

Different Risk Factors in Identical Features of Intracranial Atherosclerosis Plaques in the Posterior and Anterior Circulation in High-Resolution MRI

Assessing stroke recurrence in sICAS: a study on mCSVD score and culprit plaque magnetic resonance characteristics

Abstract TP47: Intracranial Intraplaque Hemorrhage in Acute Stroke: Interim Results of the Stroke Imaging Package Study

Risk of Recurrence of Symptomatic Intracranial Atherosclerosis in Posterior Circulation Seen to Be Higher Than That in Anterior Circulation in Long-Term Follow-Up

Refined Imaging Features of Culprit Plaques Improve the Prediction of Recurrence in Intracranial Atherosclerotic Stroke Within the Middle Cerebral Artery Territory.

Long-term recurrence of ischemic events in patients with intracranial atherosclerotic stenosis stratified by symptoms and pathogenesis

Intracranial Atherosclerotic Plaque Characteristics and Burden Associated with Recurrent Acute Stroke: A 3D Quantitative Vessel Wall MRI Study

Intracranial Plaque Characteristics of Recurrent Ischemic Stroke after Intensive Medical Therapy for a 6-Month Follow-up

Intracranial Atherosclerosis Burden and Stroke Recurrence for Symptomatic Intracranial Artery Stenosis (sICAS)

Extracranial carotid plaque hemorrhage predicts ipsilateral stroke recurrence in patients with carotid atherosclerosis - a study based on high-resolution vessel wall imaging MRI

Association between high-resolution magnetic resonance vessel wall imaging characteristics and recurrent stroke in patients with intracranial atherosclerotic steno-occlusive disease: A prospective multicenter study

Abstract 36: Association Between High-Resolution Magnetic Resonance Imaging Characteristics and Recurrent Stroke in Patients With Symptomatic Intracranial Atherosclerotic Steno-Occlusive Disease: A Prospective Multicenter Study

Large Culprit Plaque and More Intracranial Plaques Are Associated with Recurrent Stroke: A Case-Control Study Using Vessel Wall Imaging.

Correlation between characteristics of intracranial atherosclerotic plaques and ischemic stroke in high-resolution vascular wall MRI

Qualitative and quantitative plaque enhancement on high‐resolution vessel wall imaging predicts symptomatic intracranial atherosclerotic stenosis

Association of Culprit Plaque Enhancement Ratio, Hypoperfusion and HbA1c with Recurrent Ischemic Stroke in Patients with Atherosclerotic Stenosis of the Middle Cerebral Artery

Correlation of sLOX-1 Levels and MR Characteristics of Culprit Plaques in Intracranial Arteries with Stroke Recurrence

Hemodynamics and stroke risk in intracranial atherosclerotic disease

Incremental value of plaque enhancement in predicting stroke recurrence in symptomatic intracranial atherosclerosis